Market Overview:
The global molybdenum-99 market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for molybdenum-99 in medical applications and its growing use in industrial applications. Molybdenum-99 is used as a diagnostic tool in nuclear medicine and has various other medical applications such as cancer treatment, diagnosis of heart diseases, and brain imaging. It also finds application in industries such as oil & gas, metal production, automotive, aerospace & defense, and others. The market for molybdenum-99 is expected to grow significantly in Asia Pacific due to the increasing demand from countries such as China and India.
Product Definition:
Molybdenum-99 is a radioactive isotope of molybdenum that has a half-life of about 66 hours. It is used in the medical field to diagnose and treat diseases.
Production by Highly Enriched Uranium:
U.S. production by highly enriched uranium (HEU) market was valued at USD 5,500 million in 2015 and is expected to grow at a CAGR of XX% over the forecast period. HEU is used as an ingredient in the manufacturing of Molybdenum-99 (Mo-99), which has applications in medical industry for radiotherapy treatments such as cancer and heart diseases.
Production by Non-Highly Enriched Uranium:
The U.S has been the world’s largest producer of natural gas for many years, with coal being a close second; however, natural gas production is expected to decline in the future due to increasing focus on other energy sources such as wind and solar power.
Application Insights:
The industry application segment led the global market in 2017 and is projected to continue its dominance over the forecast period. The growth of this segment can be attributed to increasing demand for molybdenum-99 from various industries including medical, industrial, and nuclear power generation.
Molybdenum-99 is used in a variety of medical applications such as radioisotope thermoelectric generators (RTGs) that are used by hospitals for producing energy for their diagnostic equipment. It has also found application as a source material in the production of Molybdenum-100 which is employed in various medical procedures such as Radioisotope Thermoelectric Generator (RTG) warmers which are used by hospitals for producing energy for their diagnostic equipment.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to witness a growth rate of 5.8% over the forecast period, owing to increasing R&D activities and technological innovations in nuclear medicine that are driving demand for molybdenum-99 globally. In addition, growing medical applications for Mo-99 is also anticipated to drive regional demand over the forecast period.
Asia Pacific was estimated as the second largest consumer of Mo-99 globally after North America with a volume consumption of 1,946 kilo tons in 2017 due to rising healthcare spending and expanding application scope for molybdenum 99Mo isotopes across various industries including research & academic sector, pharmaceuticals and medical imaging among others sectors which are further boosting industry growth through its utilization in industrial processes such as chemical manufacturing or refining etc.
Growth Factors:
- Increasing demand from the medical industry for Molybdenum-99 as a diagnostic tool.
- The increasing use of Molybdenum-99 in research and development activities.
- Growing number of private and government initiatives to promote the use of nuclear medicine technologies worldwide.
- Rising demand for molybdenum from emerging economies such as China and India . 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Molybdenum-99 Market Research Report
By Type
Production by Highly Enriched Uranium, Production by Non-Highly Enriched Uranium
By Application
Medical, Industry, Santific Research, Others
By Companies
IRE, Curium Pharma, Eckert Ziegler, NTP Radioisotopes, Rosatom, International Isotopes Inc., Covidien
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Molybdenum-99 Market Report Segments:
The global Molybdenum-99 market is segmented on the basis of:
Types
Production by Highly Enriched Uranium, Production by Non-Highly Enriched Uranium
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical, Industry, Santific Research, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- IRE
- Curium Pharma
- Eckert Ziegler
- NTP Radioisotopes
- Rosatom
- International Isotopes Inc.
- Covidien
Highlights of The Molybdenum-99 Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Production by Highly Enriched Uranium
- Production by Non-Highly Enriched Uranium
- By Application:
- Medical
- Industry
- Santific Research
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Molybdenum-99 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Molybdenum-99 is a radioactive isotope of molybdenum. It has a half-life of about 87.7 days and is used in medical imaging procedures such as positron emission tomography (PET) scans and single photon emission computed tomography (SPECT).
Some of the major players in the molybdenum-99 market are IRE, Curium Pharma, Eckert Ziegler, NTP Radioisotopes, Rosatom, International Isotopes Inc., Covidien.
The molybdenum-99 market is expected to grow at a compound annual growth rate of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Molybdenum-99 Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Molybdenum-99 Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Molybdenum-99 Market - Supply Chain
4.5. Global Molybdenum-99 Market Forecast
4.5.1. Molybdenum-99 Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Molybdenum-99 Market Size (000 Units) and Y-o-Y Growth
4.5.3. Molybdenum-99 Market Absolute $ Opportunity
5. Global Molybdenum-99 Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Molybdenum-99 Market Size and Volume Forecast by Type
5.3.1. Production by Highly Enriched Uranium
5.3.2. Production by Non-Highly Enriched Uranium
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Molybdenum-99 Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Molybdenum-99 Market Size and Volume Forecast by Application
6.3.1. Medical
6.3.2. Industry
6.3.3. Santific Research
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Molybdenum-99 Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Molybdenum-99 Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Molybdenum-99 Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Molybdenum-99 Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Molybdenum-99 Demand Share Forecast, 2019-2026
9. North America Molybdenum-99 Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Molybdenum-99 Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Molybdenum-99 Market Size and Volume Forecast by Application
9.4.1. Medical
9.4.2. Industry
9.4.3. Santific Research
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Molybdenum-99 Market Size and Volume Forecast by Type
9.7.1. Production by Highly Enriched Uranium
9.7.2. Production by Non-Highly Enriched Uranium
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Molybdenum-99 Demand Share Forecast, 2019-2026
10. Latin America Molybdenum-99 Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Molybdenum-99 Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Molybdenum-99 Market Size and Volume Forecast by Application
10.4.1. Medical
10.4.2. Industry
10.4.3. Santific Research
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Molybdenum-99 Market Size and Volume Forecast by Type
10.7.1. Production by Highly Enriched Uranium
10.7.2. Production by Non-Highly Enriched Uranium
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Molybdenum-99 Demand Share Forecast, 2019-2026
11. Europe Molybdenum-99 Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Molybdenum-99 Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Molybdenum-99 Market Size and Volume Forecast by Application
11.4.1. Medical
11.4.2. Industry
11.4.3. Santific Research
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Molybdenum-99 Market Size and Volume Forecast by Type
11.7.1. Production by Highly Enriched Uranium
11.7.2. Production by Non-Highly Enriched Uranium
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Tye
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Molybdenum-99 Demand Share, 2019-2026
12. Asia Pacific Molybdenum-99 Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Molybdenum-99 Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Molybdenum-99 Market Size and Volume Forecast by Application
12.4.1. Medical
12.4.2. Industry
12.4.3. Santific Research
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Molybdenum-99 Market Size and Volume Forecast by Type
12.7.1. Production by Highly Enriched Uranium
12.7.2. Production by Non-Highly Enriched Uranium
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Molybdenum-99 Demand Share, 2019-2026
13. Middle East & Africa Molybdenum-99 Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Molybdenum-99 Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Molybdenum-99 Market Size and Volume Forecast by Application
13.4.1. Medical
13.4.2. Industry
13.4.3. Santific Research
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Molybdenum-99 Market Size and Volume Forecast by Type
13.7.1. Production by Highly Enriched Uranium
13.7.2. Production by Non-Highly Enriched Uranium
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Molybdenum-99 Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Molybdenum-99 Market: Market Share Analysis
14.2. Molybdenum-99 Distributors and Customers
14.3. Molybdenum-99 Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. IRE
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Curium Pharma
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Eckert Ziegler
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. NTP Radioisotopes
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Rosatom
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. International Isotopes Inc.
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Covidien
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
